Last update May 21, 2025
Incompatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Lindane belongs to this group or family:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 90 | % |
Molecular weight | 290 | daltons |
Protein Binding | 91 | % |
Tmax | 6 | hours |
T½ | 18 - 21 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Lindane is a chlorinated insecticide that has been used as an ectoparasiticide and ovicide in the treatment of scabies, Pediculosis humanis capitis (lice) and Phthirus pubis (crab lice). Dermatological topical application.
It is very fat soluble, is very well absorbed through the skin and is commonly found in food and breast milk.
Application of a 0.3% lindane lotion to the entire skin of a nursing mother for 24 hours raised lindane levels in milk 20 to 70 times baseline levels in the following days. (Senger 1989).
May behave as an endocrine disruptor, as it has estrogenic activity. (Massart 2005)
Occupational risk and in breastfeeding:
The former R-risk phrases or current Hazard H-phrases and precautionary labelling P-phrases relevant to breastfeeding are (INSHT 2022, UN 2011, EC Regulation 2008):
Three other H-phrases that should be considered during breastfeeding are related to the carcinogenic, mutagenic or cumulative strength of a product:
As the safety data sheet for Lindane contains the phrases H362 and H373 (INSHT 2025), the exposed breastfeeding mother should be removed from her workstation and, in general, this product should not be used during breastfeeding.
During breastfeeding safer alternatives are preferable. (Workowski 2021, Thomas 2020, Butler 2014)
It is considered a persistent environmental contaminant. Topical medications containing lindane have been withdrawn from the market in many countries. (Schaefer, 2015).
See below the information of this related product: